Why the study?
Does KB-R7943 reduce ischemia/reoxygenation injury in isolated rat cardiomyocytes and hearts?
Does KB-R7943 reduce ischemia/reoxygenation injury in isolated rat cardiomyocytes and hearts?
Inhibition of the reverse mode of the Na+/Ca2+ exchanger with KB-R7943 protects rat cardiomyocytes from ischemia-reoxygenation injury.
Answers are grounded in this paper and cite their sources.
KB-R7943 protection in rat models should not change practice; leaves open translation of reverse NCX inhibition to clinical ischemia-reperfusion.
The novel inhibitor of the reverse mode of the Na+/Ca2+ exchanger (NCE) KB-R7943 (KB) was tested in isolated rat cardiomyocytes exposed to 80 min of simulated ischemia [substrate-free anoxia, extracellular pH (pHo) of 6.4] and 15 min of reoxygenation (pHo 7.4). At pHo 6.4, 20 micromol/l KB was required for complete inhibition of the reverse mode of NCE. Treatment with 20 micromol/l KB only during anoxia did not influence the onset of rigor contracture and intracellular pH (pHi) (monitored with 2', 7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein) but significantly reduced the cytosolic accumulation of Ca2+ (monitored with fura 2) and Na+ (monitored with sodium-binding benzofuran isophthalate). During reoxygenation, cardiomyocytes developed hypercontracture. This was significantly reduced by anoxic KB treatment. To investigate this protection against reoxygenation-induced injury in the whole heart, we exposed Langendorff-perfused rat hearts to 110 min of anoxia (pHo 6.4) and 50 min of reoxygenation (pHo 7.4). Application of 20 micromol/l KB during anoxia significantly reduced the reoxygenation-induced enzyme release. We conclude that KB offers significant protection of cardiomyocytes against Ca2+ and Na+ overload during anoxia and hypercontracture or enzyme release on reoxygenation.
No takes yet. Share an insight, caveat, or question.
Ladilov et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: